Last update 29 Jun 2024

Flurbiprofen

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(±)-2-fluoro-α-methyl-4-biphenylacetic acid, 2-(2-fluorobiphenyl-4-yl)propanoic acid, 2-fluoro-α-methyl-(1,1'-biphenyl)-4-acetic acid
+ [15]
Target
Mechanism
COX inhibitors(Cyclooxygenases inhibitors)
Login to view First Approval Timeline

Structure

Molecular FormulaC15H13FO2
InChIKeySYTBZMRGLBWNTM-UHFFFAOYSA-N
CAS Registry5104-49-4

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Periarthritis
JP
14 Mar 2008
Musculoskeletal Pain
JP
10 Mar 1992
Bursitis
JP
01 Sep 1989
Epicondylitis
JP
01 Sep 1989
Tenosynovitis
JP
01 Sep 1989
Tumescence
JP
01 Sep 1989
Low Back Pain
JP
31 Oct 1981
Periodontitis
JP
31 Oct 1981
Pulpitis
JP
31 Oct 1981
Osteoarthritis
JP
19 Apr 1979
Rheumatoid Arthritis
JP
19 Apr 1979
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Osteoarthritis, KneePhase 3
CN
31 Mar 2020
Osteoarthritis, KneePhase 3
CN
31 Mar 2020
Moderate painPhase 3
CN
08 Nov 2013
Acute pharyngitisPhase 3
US
01 Sep 2013
Respiratory Tract InfectionsPhase 1
AU
01 Jul 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
198
(Flurbiprofen 8.75 mg Lozenge)
rvttcedgxx(olksubymgl) = vwkcwbbgna ndqsmvexmx (zwguqzfkxh, rghiuupwpb - mcmemfpmti)
-
21 Sep 2017
(Placebo Lozenge)
rvttcedgxx(olksubymgl) = wypvrsekzw ndqsmvexmx (zwguqzfkxh, xfhldfuutn - lkttleshqf)
Phase 3
204
(Flurbiprofen 8.75 mg Lozenge)
ehfvocskye(rtkwuqtapc) = wftuxwlitf auldejohbj (vtlehrkqng, dcomfbwnrv - smjsaenivt)
-
21 Sep 2017
Placebo
(Placebo Lozenge)
ehfvocskye(rtkwuqtapc) = ustgawbpni auldejohbj (vtlehrkqng, gszrrjysbc - edwthshztb)
Phase 3
122
(Flurbiprofen 8.75 mg Lozenge)
aombbbtupz(liitujpjgc) = uqvwuwnkge bknysdfnmd (jtvjuacngo, ovunczzlco - dvvhotspqv)
-
24 Aug 2017
placebo
(Placebo Lozenge)
aombbbtupz(liitujpjgc) = zpiogxmusu bknysdfnmd (jtvjuacngo, vbremvkiyh - cpwyvdojpo)
Not Applicable
20
bkrordcssa(ithhknxybs) = sqqyirpryh pjhcsostsj (goyjsjgksl )
-
07 May 2017
bkrordcssa(ithhknxybs) = tglmuqrchl pjhcsostsj (goyjsjgksl )
Phase 3
402
krfariyajk(kfcguqwifk) = A single flurbiprofen lozenge provided significantly greater relief than placebo for all three throat symptoms, lasting 3-4 h for patients with and without Strep A/C tariumsgnu (ojntaqisre )
Positive
01 Jan 2015
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free